DJIA 16,790.19 13.76 0.08%
NASDAQ 4,748.36 -32.90 -0.69%
S&P 500 1,979.92 -7.13 -0.36%
market minute promo

9.34 -0.21 (-2.20%)

Quote as of

company name or ticker

Recent Quotes

MACK $9.34 -2.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.50
Previous Close $9.55
Daily Range $9.18 - $9.91
52-Week Range $7.36 - $13.84
Market Cap $1.0B
P/E Ratio -10.73
Dividend (Yield) $0.00 (0.0%)
Volume 1,911,164
Average Daily Volume 1,598,575
Current FY EPS -$1.07




Drug Makers

Merrimack Pharmaceuticals, Inc. (MACK) Description

Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases with an initial focus on cancer. Website:

News & Commentary Rss Feed

Will the FDA Approve All 3 of These Cancer Drugs in October?

Three cancer drugs are slated to go before the proverbial firing squad in October. Will the Food and Drug Administration green light all three?

Merrimack Pharma Could Have FDA Approval Coming; These Analysts Are Buying

Today's Dead Cat Bounce Stock: Merrimack Pharmaceuticals (MACK)

Perilous Reversal Watch: Merrimack Pharmaceuticals (MACK)

First Week of November 20th Options Trading For Merrimack Pharmaceuticals (MACK)

3 Healthcare Stocks That Cost Less Than a Trip to Chipotle

A quick trip to Chipotle will set you back about $10. Instead of using that money to buy a delicious burrito, consider these tasty stocks.

Juno Therapeutics: Celgene Partnership And CAR-T Pipeline Value

Merrimack Pharmaceuticals (MACK) Is Today's Dead Cat Bounce Stock

10 Biotech Stocks With Catalysts Coming Soon

Friday 8/14 Insider Buying Report: SHLM, MACK

See More MACK News...